PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1489958
PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1489958
Europe Angioplasty Balloons Market is valued approximately at USD 710 million in 2023 and is anticipated to grow with a healthy growth rate of more than 4.06% over the forecast period 2024-2032. Angioplasty balloons serve as medical instruments utilized during angioplasty interventions aimed at addressing obstructed or constricted blood vessels, especially within the heart and other bodily regions. A catheter featuring an affixed balloon is carefully introduced into the impacted artery, and upon reaching the blockage, the balloon is inflated. This action exerts pressure on the plaque or fatty build-ups, expanding the vessel and reinstating proper blood circulation. Such procedures effectively alleviate conditions such as coronary artery disease and peripheral arterial disease, ultimately enhancing cardiovascular well-being. This trend is supported by developments in imaging technologies that allow for more precise diagnosis and treatment planning, such as optical coherence tomography (OCT) and intravascular ultrasonography (IVUS). The rising shift towards personalized and precision medicine in cardiovascular care is a key trend for the Europe Angioplasty Balloons Market growth.
Europe has a rapidly aging population that is representing a significant rise in chronic conditions such as coronary artery disease (CAD), a prime target for angioplasty procedures with balloons. European countries boast well-established healthcare systems that prioritize high-quality patient care. Angioplasty balloons offer a minimally invasive approach compared to open-heart surgery, aligning with this focus. The European angioplasty balloons market experiences robust growth due to surge in the demand for angioplasty procedures and associated devices such as balloons, along with the continuous technological innovations in angioplasty balloon technologies, such as drug-eluting balloons and bioresorbable scaffolds, which enhance treatment efficacy and patient outcomes. Furthermore, the well-developed healthcare infrastructure across Europe and favorable regulatory environments and approvals for medical devices, facilitates the adoption and accessibility of angioplasty balloons. Moreover, growing awareness among healthcare professionals and patients about the benefits of minimally invasive procedures such as angioplasty, alongside lifestyle factors such as sedentary behavior and rising obesity rates, which, in turn, augmenting the growth of the Europe Angioplasty Balloons Market. However, high costs associated with the procedure, coupled with the complications associated with angioplasty procedures is expected to stifle Europe Angioplasty Balloons Market growth between 2022 and 2032.
The key countries considered for the Europe Angioplasty Balloons Market study includes UK, Germany, France, Italy, Spain, and Rest of Europe. In 2023, Germany is recorded with dominating position in the Angioplasty Balloons market with the highest number of market share because of substantial healthcare expenditure supports the advanced medical technologies, accelerates the growth of the angioplasty balloons market in the region. Germany is positioned for continued growth by focusing on high-quality, innovative angioplasty balloons, minimally invasive procedures, patient safety, and cost-effectiveness, the Angioplasty Balloons Market. The market in France, on the other hand, is expected to grow at the fastest rate over the forecast period.